NASDAQ:QUCY Mainz Biomed Q4 2025 Earnings Report $1.33 +0.01 (+0.76%) Closing price 09/24/2026 04:00 PM EasternExtended Trading$1.34 +0.00 (+0.38%) As of 07:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Mainz Biomed EPS ResultsActual EPS-$0.03Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AMainz Biomed Revenue ResultsActual Revenue$0.13 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AMainz Biomed Announcement DetailsQuarterQ4 2025Date3/31/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Mainz Biomed Earnings HeadlinesQuantum Cyber Acquires NVIDIA A100 AI Compute Cluster to Power Its Swarm Operating SystemSeptember 8, 2026 | globenewswire.comQuantum Cyber NV (QUCY)September 4, 2026 | ru.investing.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.September 25 at 1:00 AM | Banyan Hill Publishing (Ad)Quantum Cyber Invites Qualified Foundries, and Prototype-Development Partners to Apply for Its Quantum-Photonic Antenna Manufacturing Program; Responses Due September 18, 2026September 4, 2026 | globenewswire.comQuantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense PlatformSeptember 2, 2026 | globenewswire.comQuantum Cyber Completes Purchase and Installation of 80-Unit 3D Printing Drone Production Farm at Its Bridgeport, Connecticut Manufacturing FacilityAugust 31, 2026 | globenewswire.comSee More Mainz Biomed Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Mainz Biomed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mainz Biomed and other key companies, straight to your email. Email Address About Mainz BiomedMainz Biomed (NASDAQ:QUCY) is a molecular diagnostics company focused on developing non-invasive tests for the early detection of cancer. The company’s technology uses molecular biomarkers and multiplex polymerase chain reaction (PCR) analysis to identify disease-related signals in patient samples. Its principal product is ColoAlert, a stool-based screening test designed to detect colorectal cancer and advanced adenomas. The test analyzes stool samples for specific genetic mutations and blood-related markers associated with colorectal disease, offering an alternative to more invasive screening procedures such as colonoscopy. Founded in 2016 and headquartered in Germany, Mainz Biomed has commercialized ColoAlert in Germany and other European markets and has pursued regulatory authorization and clinical development activities in the United States. The company has also conducted studies and collaborations intended to evaluate the test’s performance and support broader adoption of molecular colorectal cancer screening.View Mainz Biomed ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure BuildsPaychex Plunges, Providing the Entry Investors Have Been Waiting ForThe Case for Buying High-Yield General Mills Just StrengthenedEnergy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense EngineSandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock? Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
